Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 3
1963 4
1964 2
1965 7
1966 8
1967 5
1968 9
1969 3
1970 12
1971 7
1972 5
1973 2
1974 1
1976 5
1977 5
1978 5
1979 3
1980 2
1981 2
1982 1
1983 5
1984 2
1985 6
1986 5
1987 8
1988 1
1989 10
1990 11
1991 8
1992 10
1993 27
1994 15
1995 12
1996 15
1997 17
1998 15
1999 24
2000 24
2001 24
2002 20
2003 21
2004 28
2005 17
2006 14
2007 12
2008 23
2009 28
2010 21
2011 36
2012 35
2013 31
2014 38
2015 34
2016 25
2017 39
2018 21
2019 22
2020 39
2021 31
2022 24
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

830 results
Results by year
Filters applied: . Clear all
Page 1
[Lymphedema].
Takakura S, Yoshizawa I, Abo M, Ochiai K. Takakura S, et al. Among authors: ochiai k. Gan To Kagaku Ryoho. 2011 Apr;38(4):528-33. Gan To Kagaku Ryoho. 2011. PMID: 21498979 Japanese.
Post-traumatic cerebral sinus thrombosis.
Ochiai K, Nishiyama K. Ochiai K, et al. BMJ Case Rep. 2021 Feb 1;14(2):e239783. doi: 10.1136/bcr-2020-239783. BMJ Case Rep. 2021. PMID: 33526538 No abstract available.
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial.
Katsumata N, Yasuda M, Isonishi S, Takahashi F, Michimae H, Kimura E, Aoki D, Jobo T, Kodama S, Terauchi F, Sugiyama T, Ochiai K; Japanese Gynecologic Oncology Group. Katsumata N, et al. Among authors: ochiai k. Lancet Oncol. 2013 Sep;14(10):1020-6. doi: 10.1016/S1470-2045(13)70363-2. Epub 2013 Aug 13. Lancet Oncol. 2013. PMID: 23948349 Clinical Trial.
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.
Katsumata N, Yasuda M, Takahashi F, Isonishi S, Jobo T, Aoki D, Tsuda H, Sugiyama T, Kodama S, Kimura E, Ochiai K, Noda K; Japanese Gynecologic Oncology Group. Katsumata N, et al. Among authors: ochiai k. Lancet. 2009 Oct 17;374(9698):1331-8. doi: 10.1016/S0140-6736(09)61157-0. Epub 2009 Sep 18. Lancet. 2009. PMID: 19767092 Clinical Trial.
Subleukaemic T-Lymphoblastic Leukaemia in a Horse.
Michishita M, Shibata R, Machida Y, Matsumoto M, Ochiai K, Azakami D. Michishita M, et al. Among authors: ochiai k. J Comp Pathol. 2021 Oct;188:21-25. doi: 10.1016/j.jcpa.2021.08.002. Epub 2021 Sep 14. J Comp Pathol. 2021. PMID: 34686273
Altered epigenetic clock in children exposed to maltreatment.
Nishitani S, Suzuki S, Ochiai K, Yao A, Fujioka T, Fujisawa TX, Tomoda A. Nishitani S, et al. Among authors: ochiai k. Psychiatry Clin Neurosci. 2021 Mar;75(3):110-112. doi: 10.1111/pcn.13183. Epub 2020 Dec 24. Psychiatry Clin Neurosci. 2021. PMID: 33305449 Free article. No abstract available.
Involvement of Nestin in the Progression of Canine Mammary Carcinoma.
Yoshimura H, Moriya M, Yoshida A, Yamamoto M, Machida Y, Ochiai K, Michishita M, Nakagawa T, Matsuda Y, Takahashi K, Kamiya S, Ishiwata T. Yoshimura H, et al. Among authors: ochiai k. Vet Pathol. 2021 Sep;58(5):994-1003. doi: 10.1177/03009858211018656. Epub 2021 May 31. Vet Pathol. 2021. PMID: 34056976
A Variable Scheduling Maintenance Culture Platform for Mammalian Cells.
Ochiai K, Motozawa N, Terada M, Horinouchi T, Masuda T, Kudo T, Kamei M, Tsujikawa A, Matsukuma K, Natsume T, Kanda GN, Takahashi M, Takahashi K. Ochiai K, et al. SLAS Technol. 2021 Apr;26(2):209-217. doi: 10.1177/2472630320972109. Epub 2020 Dec 3. SLAS Technol. 2021. PMID: 33269985 Free PMC article.
830 results